Daiichi Sankyo Company, Limited

4568.T
Drug Manufacturers - General
2026/07/31 Updated
Market Cap: $33.2B (¥5.3T)
Stock Price: $18.23 (¥2,889)
Exchange Rate: 1 USD = ¥158.48

【Daiichi Sankyo】Continuing Stock Grant Program of U.S. Subsidiary|July 2026

Daiichi Sankyo has resolved to continue its trust-based stock grant program for officers and employees of its U.S. subsidiary, aiming to enhance engagement and attract talent. The details of the program structure and future stock acquisition plans are also provided in detail.

Importance:
Page Updated: July 31, 2026
IR Disclosure Date: July 31, 2026

Key Figures

  • Trust Period: January 15, 2025 – End of August 2029
  • Planned Stock Acquisition Amount: Approximately $145 million (Fiscal 2027), approximately $140 million (Fiscal 2028)
  • Stock Acquisition Period: May 10, 2027 – May 31, 2027 (Fiscal 2027), May 10, 2028 – May 31, 2028 (Fiscal 2028)

AI要約

Program Overview

Daiichi Sankyo has decided to continue its trust-based stock grant program (ESOP trust) for officers and employees of its U.S. subsidiary. This program aims to improve engagement among officers and employees and retain talented personnel by providing shares and cash equivalent distributions. The trust period spans from 2025 to 2029, with a fixed amount of money entrusted each year, from which shares are acquired from the market. Shares within the trust do not exercise voting rights. The details of the program revisions and specific stock acquisition plans are also included.

Future Stock Acquisition and Program Operation

Stocks will be acquired from the market with approximately $145 million in fiscal 2027 and approximately $140 million in fiscal 2028. At the end of the trust period, there are options to cancel remaining shares or continue the program; residual assets after deducting trust expenses will belong to the company. Continued operation of the program is expected to contribute to incentivizing officers and employees and supporting the company's human resource strategy.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daiichi Sankyo Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →